Mar 13, 2023 / 12:00PM GMT
Operator
Good day, everyone, and welcome to Pfizer's Analyst and Investor Call to discuss proposed acquisition of Seagen. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo, Senior Vice President and Chief Investor Relations Officer. Please go ahead, sir.
Christopher J. Stevo - Pfizer Inc. - Senior VP & Chief IR Officer
Thank you for joining our call today on short notice. Today's call will last approximately 60 minutes. We will start with some prepared remarks followed by a question-and-answer session. Before I begin, let me remind you that Pfizer and Seagen will be making forward-looking statements during the course of this call that are subject to substantial risks and uncertainties. We undertake no obligation to update those statements and any comments we make are valid only as of today. For additional information, please see the press release regarding the proposed transaction that we issued today and the SEC Form 10-Q and 10-K filings with the companies in the sections entitled Risk Factors and Forward-Looking
Pfizer Inc Analyst and Investor Call to Discuss Proposed Acquisition of Seagen Inc Call Transcript
Mar 13, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers